I’ve been recommending this to my patients since residency. So wonderful to see this study. Everyone can benefit, even doctors, not just those with depressive symptoms #Mindfulness

Live Patient Advocate Q&A with members of the FDA Breast Team TODAY. Look forward to answer your questions again this year! View on Alamo Breast Cancer Facebook page or here starting at 11:45am with an advocate chat followed by Panel at 12:00p #bcsm @sandisues alamobreastcancer.org

Being virtual SABCS this year makes me lose track of what time zone I’m in. Today’s Advocate Chat with FDA IS 11:45AM CST or 12:45P EST. Can’t wait to chat with #bcsm Advocates about what we do on the breast team. Open for all to watch alamobreastcancer.org

If you missed the patient Q&A today with the FDA breast team, you can still watch on the Alamo Breast Cancer Facebook page. Huge thank you to the Advocates for your questions!

#SABCS20 #bcsm #advocacy colleagues, in case you missed it, there was a Facebook Live session earlier today sponsored by Alamo #BreastCancer Foundation featuring 4 of FDA's breast oncologists answering audience Q&As. You can watch it here: facebook.com/alamobreastcan…

This is everything 👉🏻 ‘’From “Empire State of Mind” to “(I Left My Heart) In San Francisco” to “Streets of Philadelphia” and “Miami,” there are innumerable love songs penned to American cities. This is a love song for San Antonio’’ SABCS

Project Orbis: Strengthening International Collaboration for Oncology Product Reviews, Faster Patient Access to Innovative Therapies #ProjectOrbis ow.ly/BO3l50CG6ZH

Feb 9, 2021 #FDAODAC votes 10-0 in favor of waiting until more data are available from Keynote-522 to make a regulatory decision on pembrolizumab in combo with chemo for neoadjuvant+pembro monotherapy for adjuvant Tx of pts w/high-risk early triple-negative breast cancer #bcsm

The OCE Patient-Friendly Language Project began with a vision that one day commonly used clinical trials terms could be defined so they are easier for patients and healthcare providers to understand. So happy to see this resource now available 👇🏻

fda.gov/about-fda/onco… I worked on this with the FDA focus group last year and it is finally live. We have made the clinical trial language used more patient friendly. So proud to continually use my voice to help others. Yep I’m crying. 👑👑👑

Welcome to our family, Lexi! 8 week old German Shepherd 🐾 It’s peak bloom here, & she loved eating the Cherry Blossom petals off the ground.😂 Follow her adventurous life on Instagram @DistrictLexi.gsd while she explores DC #puppy #GermanShepherd #CherryBlossomDC Washingtonian 🌸

#SABCS21 #bcsm There was a question about access to investigational agents via #CompassionateUse during the discussion of elig criteria for #OncTwitter #clinicaltrials in today’s Alamo Breast Cancer-FDA session SABCS. Here’s the info for #ProjectFacilitate. #regulatory

In 2016, as part of President Donald J. Trump vision for the #CancerMoonshot, National Cancer Institute instituted a policy of research #DataSharing. Now all government research will follow similar policies to speed the progress of discovery to make an impact on the lives of Americans: whitehouse.gov/ostp/news-upda…

On May 4, don't miss this discussion of misinformation about cancer and its consequences. Confirmed panelists include Julie Gralow Neal Augenstein @Chou_sylvia Eleonora Teplinsky, MD, FASCO Angus Rohan Chen #ConversationOnCancer #OCEProjectCommunity Info & registration: fda.gov/science-resear…

#cancermisinformation on the internet is hurting patients trying to find reliable resources about their cancer online. Join us in a live panel discussion with an incredible panel, May 4th! Look forward to moderating this event!

Register now for the highly-anticipated “Cancer Misinformation: Truth or Consequences” discussion. Confirmed panelists include Dr. Julie Gralow Julie Gralow Chief Medical Officer and Executive Vice President ASCO. #ConversationsOnCancer Info & registration: fda.gov/science-resear…

One of the key messages from all of the the panelists was that we all need to tackle cancer misinformation together. It will take a village and a shared effort from all health care professionals and patients, caregivers, communities. We all have a part to play. FDA Oncology

I want to say I appreciate FDA Oncology coming out from behind the curtain and discussing with patients and clinicians their thoughts & rationale around recent approvals. Great session, SABCS 👏🏻